Advertise here with Carbon Ads

This site is made possible by member support. 💞

Big thanks to Arcustech for hosting the site and offering amazing tech support.

When you buy through links on kottke.org, I may earn an affiliate commission. Thanks for supporting the site!

kottke.org. home of fine hypertext products since 1998.

Beloved by 86.47% of the web.

🍔  💀  📸  😭  🕳️  🤠  🎬  🥔

This seems promising: researchers have demonstrated that a “nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice”.

Comments  2

Sort by: thread — thread . latest . faves

M
Michael Miller

These studies are always hailed as "promising" but rarely deliver any benefit to humans, and are carried out by giving cancer to mice, then "treating them". Sorry, it is wrong to make sentient beings suffer this way for a curre that almost certainly will not materialize.

J
Jack Loftus

Never materialize? It's literally materialized, in mice. That's a start, a first step—as is always the case with scientific discovery, where true advancements are almost always rare and involve failure more than they do progres. So, I celebrate the mice, their contribution to science, and fully recognize their suffering. They are doing far more for this earth by dying than those who would idealistically believe that progress and medical advancement are somehow possible without hard work, difficult choices and, yes, suffering. When in human history has progress happened without it?

Reply in this thread

Hello! In order to leave a comment, you need to be a current kottke.org member. If you'd like to sign up for a membership to support the site and join the conversation, you can explore your options here.

Existing members can sign in here. If you're a former member, you can renew your membership.

Note: If you are a member and tried to log in, it didn't work, and now you're stuck in a neverending login loop of death, try disabling any ad blockers or extensions. Or try logging out and then back in. Still having trouble? Email me!